![Paul Rounding](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Rounding is Chairman and Chief Executive Officer of Artemis Pharmaceuticals GmbH.
He joined ARTEMIS in January 2000.
Previously, he held various positions in the pharmaceutical business group at Bayer AG.
Dr. Rounding received a BS degree in Pharmacology from the University of Bath and a PhD in Pharmacology from London University.
| Unternehmen | Position | Ende |
|---|---|---|
Taconic Biosciences GmbH
 Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Corporate Officer/Principal | 01.09.2012 |
| BAYER AG | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Researches genetics and functional genomics | Commercial Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
